OPRL1 Antikörper (AA 323-370)

Produktnummer ABIN7161665

Produktdetails anti-OPRL1 Antikörper

Target: OPRL1 (Opiate Receptor-Like 1 (OPRL1))

Bindungsspezifität: AA 323-370

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser OPRL1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Immunofluorescence (IF)

Kreuzreaktivität: Human, Maus

Aufreinigung: >95%, Protein G purified

Immunogen: Recombinant Human Nociceptin receptor protein (323-370AA)

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Recommended dilution: WB:1:500-1:5000, IF:1:200-1:500,

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Details zu OPRL1

Target: OPRL1 (Opiate Receptor-Like 1 (OPRL1))

Andere Bezeichnung: OPRL1 (OPRL1 Produkte)

Synonyme: KOR-3 antikoerper, NOCIR antikoerper, OOR antikoerper, ORL1 antikoerper, KOR3 antikoerper, LC132 antikoerper, MOR-C antikoerper, OFQR antikoerper, Oprl antikoerper, XOR1 antikoerper, OPRL antikoerper, ORGC antikoerper, morc antikoerper, opioid related nociceptin receptor 1 antikoerper, opiate receptor-like 1 L homeolog antikoerper, opiate receptor-like 1 antikoerper, opioid receptor-like 1 antikoerper, OPRL1 antikoerper, oprl1.L antikoerper, LOC100335303 antikoerper, Oprl1 antikoerper

Hintergrund:

Background: G-protein coupled opioid receptor that functions as receptor for the endogenous neuropeptide nociceptin. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors. Signaling via G proteins mediates inhibition of adenylate cyclase activity and calcium channel activity. Arrestins modulate signaling via G proteins and mediate the activation of alternative signaling pathways that lead to the activation of MAP kinases. Plays a role in modulating nociception and the perception of pain. Plays a role in the regulation of locomotor activity by the neuropeptide nociceptin.

Aliases: H.sapiens mRNA for ORL1 receptor antibody, Kappa type 3 opioid receptor antibody, Kappa-type 3 opioid receptor antibody, kappa3-related opioid receptor antibody, KOR 3 antibody, KOR-3 antibody, KOR3 antibody, LC132 receptor like antibody, LC132 receptor, rat, homolog of antibody, MGC34578 antibody, Nociceptin receptor antibody, Nociceptin/orphanin FQ (N/OFQ) peptide receptor antibody, NOCIR antibody, NOP antibody, OOR antibody, Opiate receptor like 1 antibody, Opiod receptor like 1 antibody, Oprl1 antibody, OPRX_HUMAN antibody, ORL1 antibody, Orphanin FQ receptor antibody

UniProt: P41146